Showing 181 - 200 results of 1,775 for search '"Therapy"', query time: 0.09s Refine Results
  1. 181

    WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis by Weiliang Jiang, Bingjie Guan, Hongcheng Sun, Yushuai Mi, Sanjun Cai, Rong Wan, Xinxiang Li, Peng Lian, Dawei Li, Senlin Zhao

    Published 2025-02-01
    “…Moreover, CAMKII inhibition increases the efficacy of anti-PD-1 therapy in mouse model of LM. Serum expression of WNT11 is identified as a potential minimally invasive biomarker in the management of colorectal cancer-LM with immunotherapy. …”
    Get full text
    Article
  2. 182
  3. 183

    Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment by N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova, L. Y. Koroleva

    Published 2020-07-01
    “…Description of risk factors, pathogenesis and treatment strategies of gastrointestinal bleeding (GIB) in the course of antithrombotic therapy in patients with coronary heart disease (CHD).Key points. …”
    Get full text
    Article
  4. 184

    BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy by Vinay K. Pattalachinti, Emaan Haque, Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Michael Overman, Christine M. Parseghian, Van K. Morris, Bryan Kee, Ryan W. Huey, Kanwal Raghav, Colin M. Court, John Paul Shen

    Published 2025-02-01
    “…Abstract Appendiceal Adenocarcinoma (AA) is a rare gastrointestinal cancer with no FDA-approved targeted therapies. Here, we retrospectively compare BRAF-mutant AA and colorectal cancer (CRC). …”
    Get full text
    Article
  5. 185

    Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

    Published 2024-08-01
    “…Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). This review addresses these conundrums in light of Pasteur’s principle that “the terrain is as important as the germ”. …”
    Get full text
    Article
  6. 186

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Keneth Iceland, Kasozi

    Published 2021
    Subjects: “…COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola…”
    Get full text
    Article
  7. 187
  8. 188
  9. 189
  10. 190

    Helping abused and traumatised children: Intergrating directive and non directive approaches / by Gil, Eliana

    Published 2006
    Subjects: “…Play therapy…”
    View in OPAC
    Book
  11. 191
  12. 192

    Manual of Otolaryngology : Diagnosis and Therapy /

    Published 1992
    Subjects: “…Otorhinolaryngologic Diseases therapy handbooks. 1079…”
    View in OPAC
    Book
  13. 193

    1,25-Vitamin D-mediated hypercalcaemia in the setting of immune therapy-related sarcoid-like reaction by R K Dharmaputra, N Sheriff, S Ravichandran

    Published 2025-02-01
    “…Hypercalcaemia was effectively treated with intravenous fluids and medical therapy including a short course of subcutaneous calcitonin, a total of 120 mg of denosumab and oral prednisolone.…”
    Get full text
    Article
  14. 194
  15. 195
  16. 196

    Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy by Diana Peixoto, João M. Ravasco, Barbara Blanco-Fernandez, Francisco Veiga, Angel Concheiro, João Conde, Ana Cláudia Paiva-Santos, Carmen Alvarez-Lorenzo

    Published 2025-04-01
    “…The findings reported here indicate that VD3S-PEG micelles may have a promising role in PDAC therapy, since VD3 could act not only as a hydrophobic core of the micelles but also as a therapeutic agent that provides synergetic therapeutic effects with the encapsulated PTX.…”
    Get full text
    Article
  17. 197
  18. 198
  19. 199

    High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis by Jing Wang, Ling Wu, Yu-Ling Yan, Bo Qiu, Song-Bai Deng, Xiao-Dong Jing, Jian-Lin Du, Ya-Jie Liu, Qiang She

    Published 2015-05-01
    “…More studies are needed to credibly evaluate the effects of high-intensity statin therapy in patients with CKD.…”
    Get full text
    Article
  20. 200